NT-proBNP: When is it useful in Obstetric Medicine?

Authors:

Abstract
Pregnancy, viewed as a stress test of the haemodynamic system, may unmask underlying cardiac disease. Pregnancy may also induce de novo cardiac disease. N-terminal pro brain-type natriuretic peptide is a useful biomarker in all clinical conditions in which the ventricle is stressed and especially stretched in the general population. In hypertensive diseases of pregnancy, increased levels of N-terminal pro brain-type natriuretic peptide in preeclampsia are associated with increased cardiac filling pressures and diastolic dysfunction. Increased levels of N-terminal pro brain-type natriuretic peptide in pregnant women with known cardiac disease may lead to earlier diagnosis of impending heart failure. Similarly, elevated levels of N-terminal pro brain-type natriuretic peptide assist with the diagnosis of peripartum cardiomyopathy and are increasingly used in follow-up. Women with known congenital heart disease who are pregnant can be screened for risk of cardiac events such as heart failure by the use of N-terminal pro brain-type natriuretic peptide levels. There is a paucity of data in pregnancy with the use of N-terminal pro brain-type natriuretic peptide and more research is needed.

This publication has 22 references indexed in Scilit: